Literature DB >> 19008778

Toll-like receptors in ischemia-reperfusion injury.

Thiruma V Arumugam1, Eitan Okun, Sung-Chun Tang, John Thundyil, Stephen M Taylor, Trent M Woodruff.   

Abstract

Ischemia-reperfusion (I/R) injuries are implicated in a large array of pathological conditions such as myocardial infarction, cerebral stroke, and hepatic, renal, and intestinal ischemia, as well as following cardiovascular and transplant surgeries. The hallmark of these pathologies is excessive inflammation. Toll-like receptors (TLRs) are recognized as one of the main contributors to pathogen-induced inflammation and, more recently, injury-induced inflammation. Endogenous ligands such as low-molecular hyaluronic acid, fibronectin, heat shock protein 70, and heparin sulfate were all found to be cleaved in the inflamed tissue and to activate TLR2 and TLR4, initiating an inflammatory response even in the absence of pathogens and infiltrating immune cells. In this review, we discuss the contribution of TLR activation in hepatic, renal, cerebral, intestinal, and myocardial I/R injuries. A greater understanding of the role of TLRs in I/R injuries may aid in the development of specific TLR-targeted therapeutics to treat these conditions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19008778     DOI: 10.1097/SHK.0b013e318193e333

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  121 in total

1.  Ischemic transient neurological events identified by immune response to cerebral ischemia.

Authors:  Glen C Jickling; Xinhua Zhan; Boryana Stamova; Bradley P Ander; Yingfang Tian; Dazhi Liu; Shara-Mae Sison; Piero Verro; S Claiborne Johnston; Frank R Sharp
Journal:  Stroke       Date:  2012-02-02       Impact factor: 7.914

Review 2.  Toll-like receptors: new players in myocardial ischemia/reperfusion injury.

Authors:  Tuanzhu Ha; Li Liu; Jim Kelley; Race Kao; David Williams; Chuanfu Li
Journal:  Antioxid Redox Signal       Date:  2011-04-08       Impact factor: 8.401

3.  Pterostilbene attenuates inflammation in rat heart subjected to ischemia-reperfusion: role of TLR4/NF-κB signaling pathway.

Authors:  Chen Wang; Hourong Sun; Yi Song; Zengshan Ma; Gong Zhang; Xinghua Gu; Lei Zhao
Journal:  Int J Clin Exp Med       Date:  2015-02-15

4.  Enteral arginine modulates inhibition of AP-1/c-Jun by SP600125 in the postischemic gut.

Authors:  Kechen Ban; Rachel Santora; Rosemary A Kozar
Journal:  Mol Cell Biochem       Date:  2010-10-29       Impact factor: 3.396

Review 5.  Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis.

Authors:  Hans-Joachim Anders; Liliana Schaefer
Journal:  J Am Soc Nephrol       Date:  2014-04-24       Impact factor: 10.121

Review 6.  Innate and adaptive immune responses to cell death.

Authors:  Kenneth L Rock; Jiann-Jyh Lai; Hajime Kono
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

Review 7.  Sensing damage by the NLRP3 inflammasome.

Authors:  Jaklien C Leemans; Suzanne L Cassel; Fayyaz S Sutterwala
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

8.  Human intestinal ischemia-reperfusion-induced inflammation characterized: experiences from a new translational model.

Authors:  Joep Grootjans; Kaatje Lenaerts; Joep P M Derikx; Robert A Matthijsen; Adriaan P de Bruïne; Annemarie A van Bijnen; Ronald M van Dam; Cornelis H C Dejong; Wim A Buurman
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

9.  Changes in intestinal Toll-like receptors and cytokines precede histological injury in a rat model of necrotizing enterocolitis.

Authors:  Yuying Liu; Limin Zhu; Nicole Y Fatheree; Xiaoqin Liu; Susan E Pacheco; Nina Tatevian; Jon Marc Rhoads
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-07-16       Impact factor: 4.052

10.  Extracellular BCL2 proteins are danger-associated molecular patterns that reduce tissue damage in murine models of ischemia-reperfusion injury.

Authors:  Akiko Iwata; Vicki Morgan-Stevenson; Barbara Schwartz; Li Liu; Joan Tupper; Xiaodong Zhu; John Harlan; Robert Winn
Journal:  PLoS One       Date:  2010-02-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.